financetom
Business
financetom
/
Business
/
Day One Biopharmaceuticals Insider Sold Shares Worth $1,081,191, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Day One Biopharmaceuticals Insider Sold Shares Worth $1,081,191, According to a Recent SEC Filing
May 6, 2024 12:51 AM

03:22 AM EDT, 05/06/2024 (MT Newswires) -- Charles N York II, Chief Operating and Financial Officer, Secretary, on May 01, 2024, sold 60,461 shares in Day One Biopharmaceuticals ( DAWN ) for $1,081,191. Following the Form 4 filing with the SEC, York has control over a total of 217,293 shares of the company, with 217,293 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1845337/000141588924012253/xslF345X03/form4-05032024_100559.xml

Price: 17.25, Change: +0.08, Percent Change: +0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved